Vaddi; Krishna

Patent Applications and Registrations

Patent applications and USPTO patent grants for Vaddi; Krishna.The latest application filed is for "selective inhibitors of protein arginine methyltransferase 5 (prmt5)".

Company Profile

7.14.25

Vaddi; Krishna - Chadds Ford PA
Vaddi; Krishna - Kennett Square PA
Vaddi; Krishna - Hockessin DE US
Vaddi; Krishna - Kenneth Square PA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5) App 20220218732 - Luengo; Juan ; et al.	2022-07-14
Selective inhibitors of protein arginine methyltransferase 5 (PRMT5) Grant 11,220,524 - Luengo , et al. January 11, 2	2022-01-11
Selective Inhibitors Of Protein Arginine Methyltransferase 5 (prmt5) App 20210130388 - LUENGO; Juan ; et al.	2021-05-06
Jak1 Inhibitors For The Treatment Of Myelodysplastic Syndromes App 20210069193 - Vaddi; Krishna	2021-03-11
High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients App 20210069115 - Vaddi; Krishna ; et al.	2021-03-11
High surface-area lyophilized compositions comprising arsenic for oral administration in patients Grant 10,653,628 - Vaddi , et al.	2020-05-19
High Surface-Area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients App 20200060974 - Vaddi; Krishna ; et al.	2020-02-27
High surface-area lyophilized compositions comprising arsenic for oral administration in patients Grant 10,272,045 - Vaddi , et al.	2019-04-30
Jak1 Inhibitors For The Treatment Of Myelodysplastic Syndromes App 20190111058 - Vaddi; Krishna	2019-04-18
High Surface-area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients App 20190029963 - Vaddi; Krishna ; et al.	2019-01-31
High surface-area lyophilized compositions comprising arsenic for oral administration in patients Grant 10,111,836 - Vaddi , et al. October 30, 2	2018-10-30
High Surface-area Lyophilized Compositions Comprising Arsenic For Oral Administration In Patients App 20160235679 - Vaddi; Krishna ; et al.	2016-08-18
Compositions, methods and kits relating to HER-2 cleavage Grant 9,345,677 - Friedman , et al. May 24, 2	2016-05-24
Heteroaryl substituted pyrrolo[2,3-B] pyridines and pyrrolo[2,3-B] pyrimidines as Janus kinase Grant 9,206,187 - Rodgers , et al. December 8, 2	2015-12-08
Jak1 Inhibitors For The Treatment Of Myelodysplastic Syndromes App 20150246046 - Vaddi; Krishna	2015-09-03
Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors App 20150238492 - Rodgers; James D. ; et al.	2015-08-27
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors Grant 8,946,245 - Rodgers , et al. February 3, 2	2015-02-03
Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors Grant 8,933,086 - Rodgers , et al. January 13, 2	2015-01-13
Azepine Inhibitors Of Janus Kinases App 20140031344 - Arvanitis; Argyrios G. ; et al.	2014-01-30
Heteroaryl Substituted Pyrrolo[2,3-B]Pyridines And Pyrrolo[2,3-B]Pyrimidines As Janus Kinase Inhibitors App 20140018374 - Rodgers; James D. ; et al.	2014-01-16
Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors App 20140005210 - Rodgers; James D. ; et al.	2014-01-02
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors Grant 8,541,425 - Rodgers , et al. September 24, 2	2013-09-24
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20130137681 - Rodgers; James D. ; et al.	2013-05-30
Azepine Inhibitors Of Janus Kinases App 20120329782 - Arvanitis; Argyrios G. ; et al.	2012-12-27
Compositions, Methods And Kits Relating To Her-2 Cleavage App 20120263676 - Friedman; Steven M. ; et al.	2012-10-18
Compositions, methods and kits relating to Her-2 cleavage Grant 8,088,737 - Friedman , et al. January 3, 2	2012-01-03
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20110224157 - Rodgers; James D. ; et al.	2011-09-15
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20110223210 - Rodgers; James D. ; et al.	2011-09-15
Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases Grant 7,910,108 - Friedman , et al. March 22, 2	2011-03-22
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20100022522 - Rodgers; James D. ; et al.	2010-01-28
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20090181959 - Rodgers; James D. ; et al.	2009-07-16
Sheddase Inhibitors Combined With Cd30-binding Immunotherapeutics For The Treatment Of Cd30 Positive Diseases App 20070280943 - Friedman; Steven M. ; et al.	2007-12-06
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors App 20070135461 - Rodgers; James D. ; et al.	2007-06-14
Compositions, methods and kits relating to Her-2 cleavage App 20040247602 - Friedman, Steven M. ; et al.	2004-12-09

Company Registrations

SEC

0001824633

Vaddi Krishna

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.